Dogwood Therapeutics Inc. Ordinary Shares DWTX 深沪

已收盘 12-19 16:00:00 美东时间

+0.300

+4.92%

华盛通

个股概要

公司名称	--
行业分类	--
业务描述	Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

派息除权日	每股总股息	派息日期